Analysts Set Integer Holdings Co. (NYSE:ITGR) Price Target at $137.29

Integer Holdings Co. (NYSE:ITGR) has earned an average recommendation of “Moderate Buy” from the seven brokerages that are covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is $138.71.

Several equities analysts recently commented on ITGR shares. Benchmark restated a “buy” rating and set a $130.00 target price on shares of Integer in a research report on Wednesday, October 2nd. Bank of America lifted their price target on Integer from $135.00 to $145.00 and gave the stock a “buy” rating in a research note on Tuesday, October 1st. Truist Financial lifted their price target on Integer from $145.00 to $150.00 and gave the stock a “buy” rating in a research note on Monday. KeyCorp lifted their price target on Integer from $139.00 to $144.00 and gave the stock an “overweight” rating in a research note on Tuesday. Finally, Citigroup lifted their price target on Integer from $124.00 to $130.00 and gave the stock a “neutral” rating in a research note on Tuesday, October 1st.

Integer Trading Down 0.7 %

Shares of ITGR stock opened at $131.46 on Friday. Integer has a 12 month low of $69.40 and a 12 month high of $133.52. The company has a quick ratio of 1.96, a current ratio of 3.29 and a debt-to-equity ratio of 0.73. The business’s 50 day moving average is $125.84 and its two-hundred day moving average is $120.34. The company has a market cap of $4.40 billion, a PE ratio of 45.49, a price-to-earnings-growth ratio of 1.86 and a beta of 1.08.

Integer (NYSE:ITGR) last released its quarterly earnings data on Thursday, July 25th. The medical equipment provider reported $1.30 earnings per share for the quarter, beating the consensus estimate of $1.24 by $0.06. The business had revenue of $436.20 million for the quarter, compared to analysts’ expectations of $437.00 million. Integer had a return on equity of 11.48% and a net margin of 6.31%. Integer’s revenue for the quarter was up 9.0% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.14 EPS. Equities analysts predict that Integer will post 5.3 EPS for the current year.

Insiders Place Their Bets

In related news, Director Jean M. Hobby sold 11,960 shares of the firm’s stock in a transaction that occurred on Wednesday, July 31st. The stock was sold at an average price of $119.66, for a total transaction of $1,431,133.60. Following the completion of the transaction, the director now owns 2,280 shares of the company’s stock, valued at $272,824.80. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 2.00% of the company’s stock.

Institutional Trading of Integer

A number of institutional investors and hedge funds have recently modified their holdings of ITGR. Contravisory Investment Management Inc. boosted its stake in shares of Integer by 55.9% in the 3rd quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 80 shares during the last quarter. Quest Partners LLC boosted its stake in shares of Integer by 3,688.9% in the 2nd quarter. Quest Partners LLC now owns 341 shares of the medical equipment provider’s stock worth $39,000 after buying an additional 332 shares during the last quarter. GAMMA Investing LLC boosted its stake in shares of Integer by 60.9% in the 2nd quarter. GAMMA Investing LLC now owns 375 shares of the medical equipment provider’s stock worth $43,000 after buying an additional 142 shares during the last quarter. Headlands Technologies LLC purchased a new position in shares of Integer in the 1st quarter worth $106,000. Finally, Innealta Capital LLC purchased a new position in shares of Integer in the 2nd quarter worth $110,000. Institutional investors own 99.29% of the company’s stock.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.